Clinical Trial Update: A Phase 2A Study of a Novel Antimalarial Pyrrolidinamide in Adult Patients With Uncomplicated P. Falciparum Malaria [Phase 2]

View source ↗

Summary

A Phase 2A study is evaluating a novel antimalarial pyrrolidinamide in adults with uncomplicated falciparum malaria. The trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria

Drugs mentioned

• Pyrrolidinamide (Pyrrolidinamide)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria, Falciparum | Phase 2 | Status: NOT_YET_RECRUITING